146 related articles for article (PubMed ID: 23828323)
1. Effects of levodopa on retina in Parkinson disease.
Sen A; Tugcu B; Coskun C; Ekinci C; Nacaroglu SA
Eur J Ophthalmol; 2014; 24(1):114-9. PubMed ID: 23828323
[TBL] [Abstract][Full Text] [Related]
2. [A clinical study of changes in retina and visual field in patients with early Parkinson's disease].
Li L; Ji X; Mao C; Chen Y; Guo S; Li S; Liu C
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):521-4. PubMed ID: 26359014
[TBL] [Abstract][Full Text] [Related]
3. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.
Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C
Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112
[TBL] [Abstract][Full Text] [Related]
4. Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.
Bittersohl D; Stemplewitz B; Keserü M; Buhmann C; Richard G; Hassenstein A
Acta Ophthalmol; 2015 Nov; 93(7):e578-84. PubMed ID: 26267660
[TBL] [Abstract][Full Text] [Related]
5. Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
Jiménez B; Ascaso FJ; Cristóbal JA; López del Val J
Mov Disord; 2014 Jan; 29(1):68-74. PubMed ID: 24458320
[TBL] [Abstract][Full Text] [Related]
6. Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration.
Sari ES; Koc R; Yazici A; Sahin G; Ermis SS
J Neuroophthalmol; 2015 Jun; 35(2):117-21. PubMed ID: 25485861
[TBL] [Abstract][Full Text] [Related]
7. Photoreceptor layer thinning in idiopathic Parkinson's disease.
Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Structural and Functional Retinal Changes in Parkinson Disease.
Kaur M; Saxena R; Singh D; Behari M; Sharma P; Menon V
J Neuroophthalmol; 2015 Sep; 35(3):254-8. PubMed ID: 25807477
[TBL] [Abstract][Full Text] [Related]
9. Polyneuropathy in levodopa-treated Parkinson's patients.
Szadejko K; Dziewiatowski K; Szabat K; Robowski P; Schinwelski M; Sitek E; Sławek J
J Neurol Sci; 2016 Dec; 371():36-41. PubMed ID: 27871444
[TBL] [Abstract][Full Text] [Related]
10. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.
Yang ZJ; Wei J; Mao CJ; Zhang JR; Chen J; Ji XY; Liu JY; Shen Y; Xiong KP; Huang JY; Yang YP; Liu CF
Sleep Breath; 2016 Dec; 20(4):1285-1292. PubMed ID: 27259748
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Retinal Changes in Progressive Supranuclear Palsy and Parkinson Disease.
Gulmez Sevim D; Unlu M; Gultekin M; Karaca C; Mirza M; Mirza GE
J Neuroophthalmol; 2018 Jun; 38(2):151-155. PubMed ID: 29240574
[TBL] [Abstract][Full Text] [Related]
13. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
[TBL] [Abstract][Full Text] [Related]
14. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.
Altintaş O; Işeri P; Ozkan B; Cağlar Y
Doc Ophthalmol; 2008 Mar; 116(2):137-46. PubMed ID: 17962989
[TBL] [Abstract][Full Text] [Related]
15. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease.
Stemplewitz B; Keserü M; Bittersohl D; Buhmann C; Skevas C; Richard G; Hassenstein A
Acta Ophthalmol; 2015 Dec; 93(8):e672-7. PubMed ID: 26066643
[TBL] [Abstract][Full Text] [Related]
16. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
Goetz CG; Stebbins GT; Blasucci LM
Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
[TBL] [Abstract][Full Text] [Related]
17. Fatigue in levodopa-naive subjects with Parkinson disease.
Schifitto G; Friedman JH; Oakes D; Shulman L; Comella CL; Marek K; Fahn S;
Neurology; 2008 Aug; 71(7):481-5. PubMed ID: 18695158
[TBL] [Abstract][Full Text] [Related]
18. Retinal thinning and correlation with functional disability in patients with Parkinson's disease.
Satue M; Seral M; Otin S; Alarcia R; Herrero R; Bambo MP; Fuertes MI; Pablo LE; Garcia-Martin E
Br J Ophthalmol; 2014 Mar; 98(3):350-5. PubMed ID: 24276697
[TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
[TBL] [Abstract][Full Text] [Related]
20. Inner retinal layer thinning in Parkinson disease.
Hajee ME; March WF; Lazzaro DR; Wolintz AH; Shrier EM; Glazman S; Bodis-Wollner IG
Arch Ophthalmol; 2009 Jun; 127(6):737-41. PubMed ID: 19506190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
